Alkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed

Regulatory & Legal View source PDF Explain this filing

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹5481.00

prior close

₹5431.50

announcement price

In-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.2%-0.7% vs market

Pharmaceuticals peers, median of 156sector-0.2%-0.7% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Midcap 150 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.2

15m

-0.2

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9-0.2-0.7-0.2-0.7

Next day

-0.2+0.8-1.0+0.6-0.8

-0.3+1.2-1.5+0.8-1.1

+1.9+2.2-0.3+1.7+0.2

+1.6+2.1-0.4+1.3+0.4

+3.2+1.9+1.3+1.5+1.6

+5.6+0.4+5.3+0.4+5.3

15d

+2.7-4.4+7.2-6.1+8.9

+3.8-2.8+6.6-5.8+9.6

+1.9-2.8+4.7-7.5+9.3

-3.3-12.1+8.8-17.1+13.8

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories has received an order from the State Tax Officer in Bharuch, Gujarat demanding GST of about Rs 7.9 lakh, interest of Rs 6.0 lakh, and a penalty of Rs 79,000 for FY 2021-22, totalling roughly Rs 14.7 lakh. The order alleges excess claim of Input Tax Credit (ITC) under GST laws. The company has stated it disagrees with the demand and plans to file an appeal. Alkem has clarified there is no material impact on its financials, operations, or other activities from this order.

Likely market impact

The financial impact is negligible given the small demand amount relative to the company's size, and Alkem has confirmed no material impact. The stock is unlikely to see a meaningful reaction, though investors should track the appeal outcome.